Wechat QR code

美伦医疗微信公众号二维码.jpg

TEL:400-654-1200

Million Medical 

Stock code:871562

Phone:

400-654-1200

What do you want to know?

监护仪厂家,脑电图机,美伦,美伦医疗电子有限公司
Current position: Homepage >> News >> Company news

Medical equipment acquisition hot drug firms should correctly deal with it

The number of clicks:
Release date: 2017-05-13 00:00:00
Source: Henan Meilun Medical Electronics Co., Ltd.
share it

Beauty medical equipment acquisition hot drug firms should correctly deal with it

According to relevant data show that China's medical equipment market scale of medicine, 14% of the total size of the market, and the global level is 42%, but because of this, that might be considered more mining investment community space, and points out "the plan" will focus on support for 10 to 15 large medical equipment enterprise groups, support see 40 to 50 innovative high-tech enterprises, set up eight to 10 medical instrument science and technology industry base and 10 national innovation medical instrument product application demonstration base.These policy fully the market prospects of medical apparatus and instruments.


Meilun

According to statistics, in 2016, medical apparatus and instruments is one of the most attention by private equity and venture capital industry segment.Look from the investment case number, medical apparatus and instruments of the number of transactions is 2.58 times that of 2015 transaction amount is 3 times that of 2015, accounting for the proportion of total medical health industry transaction rose to 17.51% from 2.46% in 2011.

Industry sources said: even if meet the requirements of China's securities regulatory commission dimensions enterprise, now apply for listing, to realize the IPO also have to wait until at least 2018.So for many small medical equipment enterprises, selected by the listed company or the development of transnational merger and acquisition is also can be considered as the key path.

It is well known that the overall level of medical device industry in China and abroad have very big disparity, minimally invasive medicine is few can compete with foreign giants home star, in the domestic high-end medical equipment market under the pattern of 80% occupied by foreign capital, it has firmly seize the domestic industry cardiovascular stents around 70% market share.So companies are focused on this aspect.

Drug companies should be clear: in the process of development in this extremely pay attention to the industry innovation, technology is the critical factor in market.Want to get rapid progress, must have the courage to face the risk, the innovation risk and stable income before the two projects, make the right choice.


Medical equipment acquisition hot drug firms should correctly deal with it